A MAN has had 217 Covid-19 vaccination in less than three years, scientists have revealed.
The “hypervaccinated” patient, 62, from Germany had the jabs for “private reasons”, researchers said.
AFPA ‘MAN ‘hypervaccinated’ man has had 217 Covid-19 jabs in less than three years[/caption]
They got in touch with him after reading about his case in newspapers to see what effect the vaccines had on his immune system and if there were any .
Dr Kilian Schober, of Friedrich-Alexander-Universitat Erlangen-Nurnberg, said: “Our test case was vaccinated with a total of eight different vaccines, including different available mRNA vaccines.
“The observation that no noticeable side effects were triggered in spite of this extraordinary hypervaccination indicates that the drugs have a good degree of tolerability.”
People aged 75 or over, care home residents and immunosuppressed people will be offered another Covid vaccine in this spring, six months after their last one.
Some 7.8million people in England had their top up dose in the autumn round of jabs.
The test case, reported in The Lancet Infectious Diseases, had taken hundreds of vaccines over the last few years.
Some 134 jabs had been officially confirmed, including eight different types.
Dr Schober said: “The individual has undergone various blood tests over 29 months.
“He gave us his permission to assess the results of these analyses. In some cases, samples had been frozen, and we were able to investigate these ourselves.
“We were also able to take blood samples ourselves when the man received a further vaccination during the study at his own insistence.
“We were able to use these samples to determine exactly how the immune system reacts to the vaccination.”
Tests showed he had a large amount T-cells — disease fighting immune cells — against Covid in his blood.
We did not find any indication for a weaker immune response, rather the contrary
Katharina Kocher
He had no signs of ever being infected with the virus.
The cells showed no signs of “fatigue”, when they are less able to destroy the virus, compared to blood samples from a person who had been jabbed a regular amount of times.
Doctoral student Katharina Kocher, of FAU, said: “The number of memory cells was just as high in our test case as in the control group.
“Over all, we did not find any indication for a weaker immune response, rather the contrary.”
However, researchers said he is just one individual case and no conclusions should be made about recommendations for the public.
Dr Schober said: “Current research indicates that a three dose vaccination, coupled with regular top-up vaccines for vulnerable groups, remains the favoured approach.
“There is no indication that more vaccines are required.”
Who is eligible for a spring booster?
You’ll be able to claim a dose in a couple months time if you’re:
an adult aged 75 years and over;
a residents in a care home for older adults; or
immunosuppressed and aged five years and over
If you’re part of one of these vulnerable groups, you’ll have to wait six months after your previous dose to get the spring booster, the JCVI said.
NHSE is set to provide further operational details on the programme in due course.
The committee also confirmed which vaccines health professionals can use this spring.
These are:
Pfizer-BioNTech bivalent
Moderna bivalent
Sanofi/GSK monovalent (beta variant)
Novavax monovalent (wild-type variant) – but only when alternative products are not considered clinically suitable
Which vaccine you’re offered will depend on your age and supply in your local area.
The JCVI noted that Children under 12 will be offered a children’s formulation of the Pfizer BioNTech vaccine.